KRONOS BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.96 USD | +1.05% |
|
-7.69% | -23.20% |
| Mar. 21 | Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M | MT |
| Mar. 21 | Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar Kronos Bio, Inc.
b8f9e66242c0a35bd04fd.1EeVHWcpC4qHNWSqKoYEfQoewE4yfzEjxKa3qjd9mWk.twqjLAx5RL_ERRDEcrRmUDItowJVRkZbqNPv-nUkq1iBLKF4P28z_vZiPQ~82b30f3d1c92d2dbdd0b52e76e8270a2
Upcoming events on Kronos Bio, Inc.
Past events on Kronos Bio, Inc.
| 2024-04-10 12:00 pm | American Association for Cancer Research Meeting - Abstract No: #7550 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No: #CT158 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No: #1691 |
| 2024-03-21 07:05 am | Q4 2023 Earnings Release |
| 2024-03-05 09:10 am | TD Cowen Health Care Conference |
| 2023-12-06 11:00 am | H.C. Wainwright Precision Oncology Virtual Conference |
| 2023-11-28 04:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-13 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-02 11:00 am | Connective Tissue Oncology Society Meeting - Abstract No - 1569811 |
| 2023-10-13 04:30 pm | AACR-NCI-EORTC International Conference |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Abstract #: B159 |
| 2023-08-08 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-22 04:00 pm | Annual General Meeting |
| 2023-06-15 01:40 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-08 08:30 am | Jefferies Global Healthcare Conference |
| 2023-05-10 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-15 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-07 09:10 am | Cowen Health Care Conference |
| 2022-12-11 | American Society of Hematology Meeting - Abstract No. 2799 |
| 2022-12-11 | American Society of Hematology Meeting - Abstract No.2639 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 6,29 5,53 13.78% | 5,48 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -57,2 -70,2 18.56% | -149 -154 2.81% | -135 -132 -1.89% | -120 -122 2.08% | -93,5 |
|
EBIT Million USD | Released Forecast Spread | -16,8 | -58,0 -64,9 10.57% | -151 -150 -1.21% | -137 -137 -0.22% | -122 -127 3.84% | -96,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -88,4 -96,1 7.98% | -151 -149 -1.17% | -133 -134 0.96% | -113 -118 4.16% | -92,1 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -88,4 -95,3 7.16% | -151 -144 -4.9% | -133 -129 -2.93% | -113 -111 -1.76% | -85,0 |
|
EPS USD | Released Forecast Spread | -3,22 | -5,43 -4,42 -22.99% | -2,76 -2,72 -1.55% | -2,37 -2,40 1.25% | -1,95 -2,04 4.18% | -1,54 |
| Announcement Date | 31/07/20 | 23/03/21 | 24/02/22 | 15/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,22 5,00 -75.58% | 1,86 1,25 49.12% | 0,92 1,40 -34.5% | 2,29 1,53 49.9% | 1,00 | 1,40 | 1,48 | 1,60 | 2,50 |
|
EBITDA Million USD | Released Forecast Spread | -26,9 | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -62,4 -60,6 -2.98% | -36,4 -36,4 0.1% | -33,5 -38,7 13.45% | -33,5 -37,0 9.37% | -33,7 -33,7 0.2% | -28,5 -26,1 -9.15% | -32,2 -28,5 -12.73% | -33,8 -31,7 -6.74% | -27,3 -32,2 15.11% | -25,5 | -24,7 | -23,2 | -22,7 | -14,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -62,3 -58,8 -5.94% | -36,3 -35,8 -1.24% | -32,9 -38,2 13.94% | -32,3 -35,8 9.96% | -31,8 -34,0 6.42% | -26,2 -24,6 -6.53% | -29,7 -27,5 -8.15% | -31,4 -29,4 -6.65% | -25,3 -31,0 18.31% | -25,2 | -23,5 | -22,1 | -22,5 | -13,5 |
|
Net income Million USD | Released Forecast Spread | -62,3 -58,8 -5.94% | -36,3 -35,8 -1.24% | -32,9 -38,2 13.94% | -32,3 -35,8 9.96% | -31,8 -34,0 6.42% | -26,2 -24,6 -6.53% | -29,7 -27,5 -8.15% | -31,4 -29,4 -6.65% | -25,3 -31,0 18.31% | -25,2 | -23,5 | -22,1 | -22,5 | -13,5 |
|
EPS USD | Released Forecast Spread | -1,13 -1,10 -2.91% | -0,65 -0,66 1.22% | -0,59 -0,69 14.74% | -0,57 -0,65 12.58% | -0,56 -0,59 4.44% | -0,46 -0,44 -4.55% | -0,52 -0,48 -8.33% | -0,54 -0,51 -5.37% | -0,43 -0,53 18.1% | -0,41 | -0,39 | -0,38 | -0,36 | -0,22 |
| Announcement Date | 24/02/22 | 04/05/22 | 04/08/22 | 08/11/22 | 15/03/23 | 10/05/23 | 08/08/23 | 13/11/23 | 21/03/24 | - | - | - | - | - |
More events
Past sector events for Kronos Bio, Inc.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KRON Stock
- Calendar Kronos Bio, Inc.
